Joseph P. O'Connell
Analyst
Thank you, Everett. Good morning, everyone. I'm very pleased to share with you Astro-Med's financial results for the second quarter of fiscal 2014. As you heard from -- or and perhaps read, the company really achieved a very strong second quarter. Double-digit growth in both our orders received as well as our net sales. Our customer bookings in the quarter reached $18,241,000, representing a 20.5% increase over the prior year's second quarter. And we received strong demand from our domestic customers at $13,200,000. That represents an increment of 23.3% over the prior year, or as the international customers added another $5 million of new orders, are an increase of 13.5% over the prior year's second quarter orders from international. The double-digit growth was also evident in Astro-Med's 2 segments: Test & Measurement, including our ruggedized products; and QuickLabel Systems, including our digital color printer product lines. New orders were up 11.3% in the Test & Measurement segment, while QuickLabel Systems orders were up 25% over the prior year's second quarter orders. The company's net sales growth in the second quarter was similar to the orders received. Net sales were $17,194,000, an increase of 17.3% over the prior year's sales of a similar quarter. Domestic sales were $12,074,000, were up 11.7% over the previous year, whereas international shipments of $5,120,000 representing 30% of our total second quarter sales were up 33% over the prior year. The sales by product group were also very strong. QuickLabel Systems reported sales of $12,194,000 in the quarter. That's a record level of sales on a quarterly basis for QuickLabel Systems and achieved a growth rate of 12.8% over the prior year. The Test & Measurement segment reported sales of $4,999,000 and increased 29.6% over the previous year. The second quarter also generated improved profitability on the sales. Gross profit in the quarter was $6,923,000. That's a 24.4% -- 24.6% improvement over the prior year's second quarter gross profit and generated a margin of 40.3% against the prior year's margin of 37.9%. Operating expenses on the quarter were just a little over $6 million, representing an increment from the prior year, and consumed $0.35 above the second quarter's sales dollars. The result of operating income for the second quarter was $887,000. That's an increase of 57.3% over the operating income in the second quarter of the prior year and provided an operating margin of 5.2% as compared to the prior year's 3.8%. Our federal state and foreign income taxes provision in the quarter represents an effective tax rate of 38%, down slightly from the prior year's 39% for the same timeframe. The company also realized a -- in the quarter a positive contribution from its discontinued Grass Technologies operation where we have a contract manufacturing arrangement with the buyer. Now the contribution on a net after-tax basis was $165,000. The resulting net income for the company in the second quarter was $696,000 or $0.09 per diluted share. The company reported net income of $987,000 or $0.13 per diluted share in the previous year's second quarter. However, in profiling the second quarter's earnings per share between Astro-Med's continuing operations and discontinued operations, as our earnings per share of $0.07 per diluted share for the continuing operation a significant improvement over the prior year's earnings per share from the continuing operations of $0.04 per diluted share, while the second quarter earnings per share from the discontinued operations was $0.02 per diluted share lower than the prior year's earnings per share of discontinued operations of $0.09 per diluted share. Prior to a review of the balance sheet, a quick recap of Astro-Med's 6-month results are as follows. Our net sales for the 6-month period of $32,679,000, that's a growth rate of 12.7%. QuickLabel Systems sales in the same timeframe are $23,591,000, up 11.4% over the prior year; whereas the Test & Measurement sales of $9,088,000 have increased 16.1% over the last year. The company earned gross profits on a GAAP basis in -- for the first 6 months of $12,027,000, a mark -- or representing a margin of 36.8%. However, this result does include a product replacement reserve that we took in the first quarter of $672,000 established to address a noncompliant component received from a vendor. Excluding the reserve, the non-GAAP gross profit for the first 6 months is $12,699,000 or a margin of 38.9% and compares favorably to the prior year's gross profit margin of 38.1% for the same -- for a similar 6-month period. On a GAAP basis, the net income for the first 6 months of fiscal 2014 was $247,000 or $0.03 per diluted share. However, on a non-GAAP basis, by excluding the noncompliant component reserve mentioned earlier, the net income for the first 6-months period is $670,000 equal to $0.09 per diluted share. The prior year's net income for the 6-month period was $1,824,000, representing some $0.24 per diluted share. Quickly looking at the balance sheet. Out assets at the end of the second quarter was $75,782,000. Our equity balance at $63,600,000 represented a book value per share of $8.52. Our cash position continue to remain strong at $32,583,000. Our working capital balances of accounts receivable at $9,700,000, representing some 52 days outstanding, and inventory on a continuing operations basis at $12,500,000 represents 110 days on hand, up slightly from the year end. We spent on capital expenditures for the first 6 months, $374,000, primarily associated with machinery and equipment and information technology. And we paid dividends for the first and the second quarter at the rate of $0.07 per share per quarter of $1,047,000. Our employee population at the end of the quarter was 323 folks. That's down 18 folks from the year end, and we improved nicely on our sales per employee to $219,000, representing a 12-month trailing average as compared to a comparable period previously of $207,000 per employee. That concludes the financial review of Astro-Med's second quarter. Everett?